Article Details

Efficacy and Safety of Nipocalimab in Sjögren's Disease: Phase 2 Trial Results

Retrieved on: 2024-07-16 16:53:01

Tags for this article:

Click the tags to see associated articles and topics

Efficacy and Safety of Nipocalimab in Sjögren's Disease: Phase 2 Trial Results. View article details on hiswai:

Excerpt

Nipocalimab is an anti-neonatal Fc receptor (FcRn) monoclonal antibody that diminishes the circulating IgG and IgG autoantibody levels. Its ...

Article found on: www.physiciansweekly.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up